University of Colorado Hospital
Aurora, Colorado, 80045, United States
NCT Number: NCT04279964
The overarching goal of this project is to implement Boot Camp Translation (BCT) methodology to translate the guidelines and evidence for human papillomavirus (HPV) vaccine into a practice and provider level intervention designed to improve its acceptability and uptake.
Looking for future studies?
Notify Me9 year–26 year
All sexes
Interventional
Not applicable
Aurora, Colorado, 80045, United States
As a community engagement approach, Boot Camp Translation (BCT), is a 6-9-month iterative process that brings together multiple stakeholders, including patients, parents, and community members, to translate evidence-based guidelines and recommendations into locally relevant and meaningful messages, materials, and programs.
Aim 1: Implement BCT in three geographically distinct Colorado communities to translate the current evidence for HPV vaccination into locally relevant interventions designed to increase vaccine uptake.
Aim 2: Evaluate the impact of the BCT- designed intervention on practice-level HPV vaccination initiation rates.
The long-term goal is to develop a replicable approach and low-cost method of increasing HPV vaccine uptake that is easily adaptable to different settings and sociodemographic contexts.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
All child patients who have received health supervision at participating practices during the 12 month prior to intervention and the 12 month following intervention implementation, who are ages 9-26 years, and whose parents have not requested removal from the Colorado Immunization Information System (CIIS) will be eligible for the assessment of practice immunization rates in the pre and post periods.
Exclusion criteria
Practices in the intervention arm will participate in the Boot Camp Translation process, where BCT Community Advisory group members will come together to develop and implement practice relevant materials to promote adolescent vaccination.
No intervention. Practices will continue to behave as usual.
Time frame: Up to 12 months
Percent of 9-17 year olds who have received >=1 dose of the HPV vaccine by September 29, 2021
Time frame: 12 months
Comparison of boys vs. girls who have received >1=dose of HPV vaccine by September 29, 2021
Time frame: 12 months
Comparison of boys vs. girls who have received >1=dose of HPV vaccine by September 29, 2021
Time frame: 12 months
Comparison of boys vs. girls who have received >1=dose of HPV vaccine by September 29, 2021
Time frame: 12 months
Percent of 18-26 year olds who have received >=1 dose of the HPV vaccine by September 29, 2021
University of Colorado, Denver
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT00213590
Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications
Rouen, France
View Trial DetailsNCT05463887
Decision Support Techniques, Healthy Aging
Cleveland, Ohio, United States
View Trial DetailsNCT07141914
Arterial Occlusive Diseases, Arteriosclerosis
Plainsboro, New Jersey, United States
View Trial DetailsNCT04162626
Primary Prevention
Oslo, Norway
View Trial Details